JP2016000739A5 - - Google Patents

Download PDF

Info

Publication number
JP2016000739A5
JP2016000739A5 JP2015139845A JP2015139845A JP2016000739A5 JP 2016000739 A5 JP2016000739 A5 JP 2016000739A5 JP 2015139845 A JP2015139845 A JP 2015139845A JP 2015139845 A JP2015139845 A JP 2015139845A JP 2016000739 A5 JP2016000739 A5 JP 2016000739A5
Authority
JP
Japan
Prior art keywords
xrpd
pattern
diffractometer
angstroms
angles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015139845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016000739A (ja
JP6404186B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016000739A publication Critical patent/JP2016000739A/ja
Publication of JP2016000739A5 publication Critical patent/JP2016000739A5/ja
Application granted granted Critical
Publication of JP6404186B2 publication Critical patent/JP6404186B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015139845A 2009-08-27 2015-07-13 無水形態のピリジン誘導体 Active JP6404186B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23743509P 2009-08-27 2009-08-27
US61/237,435 2009-08-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012526048A Division JP2013503134A (ja) 2009-08-27 2010-08-25 無水形態のピリジン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017114602A Division JP2017193564A (ja) 2009-08-27 2017-06-09 無水形態のピリジン誘導体

Publications (3)

Publication Number Publication Date
JP2016000739A JP2016000739A (ja) 2016-01-07
JP2016000739A5 true JP2016000739A5 (enExample) 2017-08-10
JP6404186B2 JP6404186B2 (ja) 2018-10-10

Family

ID=42790943

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012526048A Pending JP2013503134A (ja) 2009-08-27 2010-08-25 無水形態のピリジン誘導体
JP2015139845A Active JP6404186B2 (ja) 2009-08-27 2015-07-13 無水形態のピリジン誘導体
JP2017114602A Pending JP2017193564A (ja) 2009-08-27 2017-06-09 無水形態のピリジン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012526048A Pending JP2013503134A (ja) 2009-08-27 2010-08-25 無水形態のピリジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017114602A Pending JP2017193564A (ja) 2009-08-27 2017-06-09 無水形態のピリジン誘導体

Country Status (17)

Country Link
US (1) US8796269B2 (enExample)
EP (1) EP2470545B1 (enExample)
JP (3) JP2013503134A (enExample)
KR (1) KR20120056258A (enExample)
CN (1) CN102639536B (enExample)
AU (1) AU2010288502B2 (enExample)
CA (1) CA2772168C (enExample)
DK (1) DK2470545T3 (enExample)
EA (1) EA021411B1 (enExample)
ES (1) ES2440938T3 (enExample)
IL (1) IL217922A (enExample)
IN (1) IN2012DN01292A (enExample)
MX (1) MX2012002369A (enExample)
PL (1) PL2470545T3 (enExample)
SG (1) SG178231A1 (enExample)
WO (1) WO2011023733A1 (enExample)
ZA (1) ZA201200812B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013503134A (ja) * 2009-08-27 2013-01-31 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 無水形態のピリジン誘導体
EP3915560A1 (en) 2014-06-25 2021-12-01 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists
JP6902682B2 (ja) * 2015-05-18 2021-07-14 カンディー セラピューティクス リミテッド 性ホルモン依存性疾患を治療するためのnk−1/nk−3受容体デュアルアンタゴニスト
AU2017376900A1 (en) * 2016-12-15 2019-05-23 Glaxosmithkline Intellectual Property Development Limited NRF2 compounds
EA202092131A1 (ru) 2018-03-14 2020-11-27 Кэнди Терапьютикс Лимитед Новый фармацевтический препарат, содержащий двойные антагонисты рецептора nk-1/nk-3
WO2021030335A1 (en) * 2019-08-12 2021-02-18 Millendo Therapeutics, Inc. A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof
AU2020381762B2 (en) 2019-11-15 2026-01-22 KaNDy Therapeutics Limited New chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814
EP4431512A1 (en) 2023-03-16 2024-09-18 Bayer Consumer Care AG Novel dual nk-1/nk-3 receptor antagonists
WO2025242584A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag A stable soft gelatin capsule formulation for elinzanetant
WO2025242585A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag Crystalline forms of salts of elinzanetant and compositions containing salts of elinzanetant
WO2025242583A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag Novel formulation comprising elinzanetant in a solid dispersion
WO2025261856A1 (en) * 2024-06-18 2025-12-26 Bayer Consumer Care Ag Improved process for producing an elinzanetant precursor
US12533358B1 (en) 2025-05-14 2026-01-27 Bayer Consumer Care Ag Methods of treatment with elinzanetant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60045564D1 (de) * 1999-02-24 2011-03-03 Hoffmann La Roche 4-Phenylpyridinderivate und deren Verwendung als NK-1 Rezeptorantagonisten
GB0203022D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
CN100562320C (zh) * 2003-01-31 2009-11-25 弗·哈夫曼-拉罗切有限公司 2-(3,5-二-三氟甲基-苯基)-N-[6-(1,1-二氧代-1λ6-硫代吗啉-4-基)-4-(4-氟-2-甲基-苯基)-吡啶-3-基]-N-甲基-异丁酰胺的新晶体变体
JP4490421B2 (ja) * 2003-07-03 2010-06-23 エフ.ホフマン−ラ ロシュ アーゲー 統合失調症を処置するデュアルnk1/nk3アンタゴニスト
HRP20110457T1 (hr) * 2005-09-09 2011-07-31 Glaxosmithkline Llc Derivati piridina i njihova upotreba u liječenju psihotičnih poremećaja
AU2008346110A1 (en) * 2007-12-11 2009-07-16 Cipla Ltd. Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions
GB0814340D0 (en) * 2008-08-05 2008-09-10 Smithkline Beecham Corp Anhydrous crystol form fo a pyridine derivative
JP2013503134A (ja) * 2009-08-27 2013-01-31 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 無水形態のピリジン誘導体
JP6342662B2 (ja) * 2014-01-29 2018-06-13 京セラ株式会社 ドリルおよびそれを用いた切削加工物の製造方法

Similar Documents

Publication Publication Date Title
JP2016000739A5 (enExample)
JP2018024682A5 (enExample)
JP2021530565A5 (enExample)
HRP20192132T1 (hr) Antagonist nk-1/nk-3 receptora za liječenje valunga
JP2018024670A5 (enExample)
JP2019194236A5 (enExample)
JP2011518833A5 (enExample)
RU2016146119A (ru) Новый кристалл тетрациклического соединения
JP2016065042A5 (enExample)
JP2015127343A5 (enExample)
JP2017505347A5 (enExample)
JP2018521020A5 (enExample)
JP2012107057A5 (enExample)
JP2019510768A5 (enExample)
JP2009535462A5 (enExample)
JP2013532130A5 (enExample)
JP2012111758A5 (enExample)
JP2017222697A5 (enExample)
JP2016520672A5 (enExample)
JP2009149903A5 (enExample)
JP2011510079A5 (enExample)
JP2014530818A5 (enExample)
JP2013521273A5 (enExample)
JP2013509391A5 (enExample)
JP2011037885A5 (enExample)